Bumper Offer - Urjas oil Just @ Rs. 1
Zomet SR Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Diabetes.
The right dosage of Zomet SR Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Zomet SR Tablet include Stomach Upset, Difficulty urinating. Apart from the aforementioned side effects, Zomet SR Tablet can also lead to other problems, which have been listed below. Such side effects of Zomet SR Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Zomet SR Tablet has a Mild effect for pregnant women and Moderate effect on lactating mothers. In addition, Zomet SR Tablet's effects on the liver, heart and kidney are discussed below in the Zomet SR Tablet related warnings section.
Zomet SR Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Congestive Heart Failure (CHF), Anemia, Shock are examples of such conditions. Some other conditions that can be affected by Zomet SR Tablet are listed in the contraindications section below.
Drug interactions for Zomet SR Tablet have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Zomet SR Tablet is safe while driving, and is addiction.
Zomet SR Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Is the use of Zomet SR Tablet safe for pregnant women?
Zomet has little to no side effects in pregnant women.
Is the use of Zomet SR Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Zomet. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Zomet SR Tablet on the Kidneys?
Using Zomet does not have any harmful effects on kidneys.
What is the effect of Zomet SR Tablet on the Liver?
Zomet is completely safe for the liver.
What is the effect of Zomet SR Tablet on the Heart?
Zomet is completely safe for the heart.
Zomet SR Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zomet SR Tablet unless your doctor advises you to do so -
Is this Zomet SR Tablet habit forming or addictive?
Forming a habit of Zomet SR Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Zomet SR Tablet since it does not cause drowsiness.
Is it safe?
Zomet SR Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Zomet SR Tablet in mental disorders is not effective.
Interaction between Food and Zomet SR Tablet
Information is not available on the interaction of any foods with Zomet SR Tablet, due to a lack of research on this.
Interaction between Alcohol and Zomet SR Tablet
Consuming Zomet SR Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826